0000899866-20-000094.txt : 20201218 0000899866-20-000094.hdr.sgml : 20201218 20201218170814 ACCESSION NUMBER: 0000899866-20-000094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201216 FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Franchini Indrani Lall CENTRAL INDEX KEY: 0001708764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 201401417 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS, INC STREET 2: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 4752302596 MAIL ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960111 4 1 wf-form4_160832927928084.xml FORM 4 X0306 4 2020-12-16 0 0000899866 ALEXION PHARMACEUTICALS, INC. ALXN 0001708764 Franchini Indrani Lall C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARD BOSTON MA 02210 0 1 0 0 EVP, Chief Compliance Officer Common Stock, par value $.0001 per share 2020-12-16 4 A 0 37965 0 A 66183 D Common Stock, par value $.0001 per share 2020-12-16 4 F 0 16925 157.96 D 49258 D Common Stock, par value $.0001 per share 2020-12-16 4 F 0 2913 157.96 D 46345 D Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan. This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units. This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units. /s/ Douglas J. Barry, Attorney-in-Fact for Indrani L. Franchini 2020-12-18